Karl T Weber. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Adrenergic beta-Agonists/pharmacologyAdrenergic beta-Agonists/therapeutic useAldosterone/metabolismAnimalsDiuretics/pharmacologyDiuretics/therapeutic useElectrolytes/metabolismFurosemide/pharmacologyFurosemide/therapeutic useHeart Failure/diagnostic imagingHeart Failure/drug therapyHeart Failure/metabolismHumansMyocardial Contraction/drug effectsNeurotransmitter Agents/metabolismRenin-Angiotensin System/drug effectsTimeUltrasonographyVentricular Dysfunction, Left/diagnostic imagingVentricular Dysfunction, Left/drug therapyVentricular Dysfunction, Left/metabolism
Substances: See more » Adrenergic beta-AgonistsDiureticsElectrolytesNeurotransmitter AgentsAldosteroneFurosemide
Year: 2004 PMID: 15364337 DOI: 10.1016/j.jacc.2004.06.046
Source DB: PubMed Journal: J Am Coll Cardiol ISSN: 0735-1097 Impact factor: 24.094